TD Cowen Cuts Boston Scientific and Mobileye Ratings to Hold
TD Cowen lowered its rating on Boston Scientific and Mobileye from Buy to Hold and cut the Mobileye price target to $7 from $8, Dow Jones Newswires reports.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analysts at TD Cowen downgraded their rating on Boston Scientific shares from Buy to Hold. Dow Jones Newswires reports this, citing ratings data from Benzinga. The same firm also lowered its Mobileye rating from Buy to Hold and cut its price target on the stock to $7.00 from $8.00.
Both decisions were published on October 30, 2026: the Boston Scientific change came at 18:35 UTC, and the Mobileye change at 20:14 GMT.
why it matters
Rating changes like these usually affect a single company and rarely move the broader market. For investors, the key point is the shift in analyst opinion rather than any standalone price level.
tags
instruments
sources
- Boston Scientific Cut to Hold From Buy by TD Cowen — Dow Jones Newswires, 30 October 2026 at 18:35 UTC
- Mobileye Global Cut to Hold From Buy by TD Cowen — Dow Jones Newswires, 30 October 2026 at 20:14 UTC
- Hershey Cut to Hold From Buy by TD Cowen — Dow Jones Newswires, 30 October 2026 at 20:33 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗